Identification of β-tubulin isoforms as tumor antigens in neuroblastoma

Clinical Cancer Research

Volumn 6, Issue 10, 2000, Pages 3949-3956

  Prasannan, Latha ^a   Misek, David E ^a   Hinderer, Robert ^a   Michon, Jean ^b   Geiger, James D ^a   Hanash, Samir M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; TUMOR ANTIGEN;

ADOLESCENT; AMINO TERMINAL SEQUENCE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MASS SPECTROMETRY; NEUROBLASTOMA; NEWBORN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; WESTERN BLOTTING;

ADOLESCENT; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; SILVER STAINING; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0033765389     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
2. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients
3. Human lung cancer antigens recognized by autologous antibodies: Definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3
4. Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients
5. p53 antibodies in the sera of patients with various types of cancer: A review
6. Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis
7. T serum p53 antibodies as early markers of lung cancer
8. New paths in human cancer serology
9. Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM
10. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: An analysis of antigenic targets in neural tissues
11. Anti-neurofilament protein antibodies in opsoclonusmyoclonus
12. Antibodies to Purkinje cells and peripheral nerve in opsoclonia
13. Anti-CNS antibodies in childhood neurologic diseases
14. Expression of class III β-tubulin in normal and neoplastic human tissues
15. Multiple forms of tubulin: Different gene products and covalent modifications
16. Tubulin post-translational modification - Enzymes and their mechanisms of action
17. Tubulin synthesis and assembly in differentiating neurons
18. Distribution of non-class III β tubulin isoforms in neuronal and nonneuronal tissues
19. A monoclonal antibody against the type II isotype of β tubulin. Preparation of isotypically altered tubulin
20. Preparation of a monoclonal antibody specific for class I isotype of β tubulin: The β isotypes of tubulin differ in their cellular distributions within human tissues
21. Expression of the class III β-tubulin isotype in developing neurons in culture
22. Phosphorylation of β III tubulin
23. Identification of the phosphorylated β-tubulin isotype in differentiated neuroblastoma cells
24. Microtubule dynamics in vitro are regulated by tubulin isotype composition
25. Phosphorylation of a neuronal specific β-tubulin isotype
26. Carboxyl terminal sequences of β tubulin involved in the interaction of HMW-MAPs. Studies using site-specific antibodies
27. Tubulin polyglutamylase: Partial purification and enzymatic properties
28. A combination of post-translational modification is responsible for the production of neuronal-tubulin heterogeneity
29. Analysis of tubulin proteins and peptides in neuronal and non-neuronal tissues using immobilized pH gradients
30. Distribution of glutamylated α- and β-tubulin in mouse tissues using a specific monoclonal antibody, GT335
31. Anti-tubulin antibodies in acquired demyelinating polyneuropathies
32. Anti-tubulin antibodies in a sensorimotor neuropathy patient alter tubulin polymerization
33. Autoantigens in human neuroblastoma cells
34. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases
35. Autoneurofilament antibodies in postencephalitic and idopathic Parkinson's disease
36. Anti-α- and β-tubulin IgM antibodies in dysimmune neuropathies
37. Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: Correlation to MYCN amplification and effects of retinoic acid